Narrow your search
Listing 1 - 10 of 23 << page
of 3
>>
Sort by

Book
Étude rétrospective sur les facteurs de risque, la prise en charge et le taux de complications des pancréatites chez les enfants
Authors: --- ---
Year: 2016 Publisher: Bruxelles: UCL. Faculté de médecine,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Pancreatitis is a rare disease in pediatrics. Studies have shown that it affects about 4 to 13 children out of 100.000. In addition, 10-35% of these patients will develop chronic pancreatitis. As for the children, the var10us causes of pancreatitis are traumatic, toxic, genetic, auto­ immune, infections or obstructive. Sometimes, no cause can be found ("idiopathic").Until recently; "idiopathic" pancreatitis was the leading cause of pancreatitis for children. However, the recent development of genetic screening techniques and imaging techniques indicate that many pancreatitis, previously called idiopathic, were actually genetic or malformative. The main objective of the study is to identify cases of pancreatitis and to determine the frequency of occurrence of the various causes of pancreatitis in the 59 children treated at Saint-Luc University Hospital between January 2014 and August 2016.To carry out this thesis, a comparative table with several data of the patients has been produced. Among other data, demographic information such as age, sex, ethnic origin, age of the first episode, consanguinity, presence of passive smoking have been included. Regarding the etiology of pancreatitis, it has been investigated on the basis of the TIGAR-o classification. The various complications and complementary examinations such as ultrasound, CT scan, MRI, endoscopic ultrasound and / or CWR have been listed according to each patient. The results highlighted that several etiologies were often found for the same patient. For 18.6% of children, more than 2 joint causes were responsible for pancreatitis. In the study, the etiologies found are, in order of frequency, obstruction, autoimmune origin, metabolic origin and abdominal trauma, idiopathic origin, genetic mutation and toxic/drug. Unlike adults, environmental factors do not influence the occurrence of pancreatitis concerning children. In the vast majority of cases (76.3%), no complications occurred for the children in a treatment program for about 4 years at Saint-Luc University Hospital. The most frequent complication is the pseudocyst for 17% of patients. La pancréatite est une maladie rare en pédiatrie. Les études démontrent qu'elle touche environ4 à 13 enfants sur 100.00033. En outre, 10 à 35% de ces patients évolueront vers une pancréatite chronique. Chez les enfants, les différentes causes de pancréatites sont traumatiques, toxiques, génétiques, auto-immunes, infectieuses ou obstructives. Parfois aucune cause n'est retrouvée (« idiopathique »). Jusqu'il y a peu, la pancréatite « idiopathique » était la cause principale de pancréatite chez l'enfant. Cependant le développement récent des techniques de dépistage génétique ainsi que celui des techniques d'imagerie indiquent que de nombreuses pancréatites, auparavant dites idiopathiques, étaient en réalité d'origine génétique ou malformative. L'objectif principal de l'étude est de recenser les cas de pancréatite et de définir la fréquence de survenue des différentes causes de pancréatite chez les 59 enfants suivis à l'hôpital universitaire de Saint-Luc sur une période de janvier 2014 à août 2016.Pour mener à bien ce mémoire, un tableau comparatif avec plusieurs données des patients a été réalisé. Les données démographiques (âge, sexe, origine ethnique, âge du premier épisode, consanguinité, présence d'un tabagisme passif) ont notamment été réponses. Concernant l'étiologie des pancréatites, elle a été recherchée en se basant sur la classification TIGAR-o. Les différentes complications et les différents examens complémentaires tels que l'échographie, le scanner, l'IRM, l'échographie endoscopique et/ou la CWR sont, quant à eux, répertoriés en fonction de chaque patient. Les résultats ont mis en évidence que plusieurs étiologies étaient souvent retrouvées chez un même patient. Chez 18.6% des enfants, plus de 2 causes conjointes étaient responsables d'une pancréatite. Dans l'étude, les étiologies retrouvées sont, par ordre de fréquence, une obstruction, une origine auto-immune, une origine métabolique et un traumatisme abdominal, une origine idiopathique, une mutation génétique et un toxique/médicament. Contrairement aux adultes, les facteurs environnementaux n'influencent pas la survenue de pancréatite chez l'enfant. Dans la grande majorité des cas (76.3%), aucune complication n'est survenue chez les enfants suivis en moyenne depuis 4 ans aux Cliniques Universitaires de Saint-Luc. La complication la plus fréquente est le pseudo kyste chez 17% patients.


Book
The Neonatal Immune System: A Unique Host-Microbial Interface
Authors: ---
Year: 2018 Publisher: Frontiers Media SA

Loading...
Export citation

Choose an application

Bookmark

Abstract

Emerging from the protective environment of the uterus, the newborn is exposed to a myriad of microbes, and quickly establishes a complex microbiome that shapes the infant’s biology in ways that are only now beginning to come to light. Among these exposures are a number of potential pathogens. The host responses to these pathogens in the neonatal period are unique, reflecting a developing immune system even with delivery at term. Preterm infants are delivered at a time when host defense mechanisms are even less developed and therefore face additional risk. As such, the organisms that cause disease in this period are different from the pathogens that are common in other age groups, or the disease they cause manifests in more severe fashion. Developmental alterations in both innate and adaptive immune responses in neonates have been documented among many cell types and pathways over the last several decades. Contemporary insights into the human immune system and methodologies that allow an “omics” approach to these questions have continued to provide new information regarding the mechanisms that underlie the human neonate as an “immunocompromised host.” This Research Topic highlights studies related to this unique host-pathogen interface. Contributions include those related to the innate or adaptive immune system of neonates, their response to microbial colonization or infection, and/or the pathogenesis of microbes causing disease in neonates.


Book
Périnatologie.
Author:
ISBN: 270460956X Year: 1977 Publisher: Paris : Expansion scientifique française,

Loading...
Export citation

Choose an application

Bookmark

Abstract


Book
The Neonatal Immune System: A Unique Host-Microbial Interface
Authors: ---
Year: 2018 Publisher: Frontiers Media SA

Loading...
Export citation

Choose an application

Bookmark

Abstract

Emerging from the protective environment of the uterus, the newborn is exposed to a myriad of microbes, and quickly establishes a complex microbiome that shapes the infant’s biology in ways that are only now beginning to come to light. Among these exposures are a number of potential pathogens. The host responses to these pathogens in the neonatal period are unique, reflecting a developing immune system even with delivery at term. Preterm infants are delivered at a time when host defense mechanisms are even less developed and therefore face additional risk. As such, the organisms that cause disease in this period are different from the pathogens that are common in other age groups, or the disease they cause manifests in more severe fashion. Developmental alterations in both innate and adaptive immune responses in neonates have been documented among many cell types and pathways over the last several decades. Contemporary insights into the human immune system and methodologies that allow an “omics” approach to these questions have continued to provide new information regarding the mechanisms that underlie the human neonate as an “immunocompromised host.” This Research Topic highlights studies related to this unique host-pathogen interface. Contributions include those related to the innate or adaptive immune system of neonates, their response to microbial colonization or infection, and/or the pathogenesis of microbes causing disease in neonates.


Book
The Neonatal Immune System: A Unique Host-Microbial Interface
Authors: ---
Year: 2018 Publisher: Frontiers Media SA

Loading...
Export citation

Choose an application

Bookmark

Abstract

Emerging from the protective environment of the uterus, the newborn is exposed to a myriad of microbes, and quickly establishes a complex microbiome that shapes the infant’s biology in ways that are only now beginning to come to light. Among these exposures are a number of potential pathogens. The host responses to these pathogens in the neonatal period are unique, reflecting a developing immune system even with delivery at term. Preterm infants are delivered at a time when host defense mechanisms are even less developed and therefore face additional risk. As such, the organisms that cause disease in this period are different from the pathogens that are common in other age groups, or the disease they cause manifests in more severe fashion. Developmental alterations in both innate and adaptive immune responses in neonates have been documented among many cell types and pathways over the last several decades. Contemporary insights into the human immune system and methodologies that allow an “omics” approach to these questions have continued to provide new information regarding the mechanisms that underlie the human neonate as an “immunocompromised host.” This Research Topic highlights studies related to this unique host-pathogen interface. Contributions include those related to the innate or adaptive immune system of neonates, their response to microbial colonization or infection, and/or the pathogenesis of microbes causing disease in neonates.


Book
Prediction and Management of Severe Acute Pancreatitis
Authors: ---
ISBN: 9781493909711 1493909703 9781493909704 1493909711 Year: 2015 Publisher: New York, NY : Springer New York : Imprint: Springer,

Loading...
Export citation

Choose an application

Bookmark

Abstract

This volume provides a comprehensive summary of pancreatitis and its complications, with expert recommendations on prediction and management. The text thoughtfully summarizes the current prediction models for severe acute pancreatitis, including laboratory, clinical and imaging parameters, and highlights the relative advantages and disadvantages of several of these models. Evidenced-based guidelines into medical and surgical management of both the hospitalized and discharged patient are described, with recommendations from expert authors pertaining to various clinical situations. The volume also discusses complications of acute pancreatitis and their management, including the use of cutting-edge minimally-invasive therapies. Prediction and Management of Severe Acute Pancreatitis serves as the fundamental source for those interested in and treating this disease, including practicing gastroenterologists, surgeons, radiologists, intensivists, hospitalists and pathologists.


Book
Toxins and Cancer Therapy
Author:
Year: 2021 Publisher: Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute

Loading...
Export citation

Choose an application

Bookmark

Abstract

Cancer has been a patient-specific and difficult-to-treat disease for decades, resulting in more deaths since 1900 than all other diseases except cardiovascular diseases. As societies around the world continue to shift towards an aging population, the social and economic burden created by cancer will only rise in the coming decades, necessitating continued improvement in our cancer therapies. Remarkably, in the late 1800s, bone surgeon William Coley serendipitously discovered that bacteria could be administered to patients as an effective (and sometimes toxic) form of cancer therapy known as "Coley's Toxins". His discoveries unknowingly led to two fields of cancer therapy that have been in development for decades and are now leading to significant improvements in therapy for cancer patients: immune-based and toxin-based therapies for cancer. Articles included here discuss the discoveries that emerged from Coley's Toxins that enable us to harness the immune system and microbial toxins to combat cancers, as oncology shifts from a field dominated by chemotherapy for most of the 20th century to biologic therapies that will dominate the 21st century.


Book
Toxins and Cancer Therapy
Author:
Year: 2021 Publisher: Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute

Loading...
Export citation

Choose an application

Bookmark

Abstract

Cancer has been a patient-specific and difficult-to-treat disease for decades, resulting in more deaths since 1900 than all other diseases except cardiovascular diseases. As societies around the world continue to shift towards an aging population, the social and economic burden created by cancer will only rise in the coming decades, necessitating continued improvement in our cancer therapies. Remarkably, in the late 1800s, bone surgeon William Coley serendipitously discovered that bacteria could be administered to patients as an effective (and sometimes toxic) form of cancer therapy known as "Coley's Toxins". His discoveries unknowingly led to two fields of cancer therapy that have been in development for decades and are now leading to significant improvements in therapy for cancer patients: immune-based and toxin-based therapies for cancer. Articles included here discuss the discoveries that emerged from Coley's Toxins that enable us to harness the immune system and microbial toxins to combat cancers, as oncology shifts from a field dominated by chemotherapy for most of the 20th century to biologic therapies that will dominate the 21st century.


Book
Toxins and Cancer Therapy
Author:
Year: 2021 Publisher: Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute

Loading...
Export citation

Choose an application

Bookmark

Abstract

Cancer has been a patient-specific and difficult-to-treat disease for decades, resulting in more deaths since 1900 than all other diseases except cardiovascular diseases. As societies around the world continue to shift towards an aging population, the social and economic burden created by cancer will only rise in the coming decades, necessitating continued improvement in our cancer therapies. Remarkably, in the late 1800s, bone surgeon William Coley serendipitously discovered that bacteria could be administered to patients as an effective (and sometimes toxic) form of cancer therapy known as "Coley's Toxins". His discoveries unknowingly led to two fields of cancer therapy that have been in development for decades and are now leading to significant improvements in therapy for cancer patients: immune-based and toxin-based therapies for cancer. Articles included here discuss the discoveries that emerged from Coley's Toxins that enable us to harness the immune system and microbial toxins to combat cancers, as oncology shifts from a field dominated by chemotherapy for most of the 20th century to biologic therapies that will dominate the 21st century.

Postpolio syndrome
Authors: ---
ISBN: 9781437711455 1437711456 9781560536062 1560536063 Year: 2004 Publisher: Philadelphia Hanley & Belfus

Loading...
Export citation

Choose an application

Bookmark

Abstract

Keywords

Human medicine --- Kinderverlamming --- Syndroom (ziektebeeld) --- Chronische pijn --- Diagnose --- Postpoliomyelitis syndrome --- Poliomyelitis --- Muscular Disorders, Atrophic --- Neurodegenerative Diseases --- Nervous System Diseases --- Myelitis --- Central Nervous System Viral Diseases --- Spinal Cord Diseases --- Muscular Diseases --- Neuromuscular Diseases --- Enterovirus Infections --- Central Nervous System Infections --- Diseases --- Central Nervous System Diseases --- Musculoskeletal Diseases --- Picornaviridae Infections --- Virus Diseases --- RNA Virus Infections --- Postpoliomyelitis Syndrome --- Medicine --- Health & Biological Sciences --- Infectious Diseases --- Spinal Cord Disorders --- Myelopathy --- Myelopathies --- Spinal Cord Disease --- Spinal Cord Disorder --- Central Nervous System Viral Infections --- Infections, CNS, Viral --- Infections, Viral CNS --- Viral Infections, Central Nervous System --- CNS Viral Diseases --- Viral Diseases, Central Nervous System --- CNS Infection, Viral --- CNS Infections, Viral --- CNS Viral Disease --- Disease, CNS Viral --- Diseases, CNS Viral --- Infection, Viral CNS --- Viral CNS Infection --- Viral CNS Infections --- Viral Disease, CNS --- Viral Diseases, CNS --- Infectious Myelitis --- Inflammation, Spinal Cord --- Myelopathy, Inflammatory --- Spinal Cord Inflammation --- Subacute Necrotizing Myelitis --- Inflammations, Spinal Cord --- Inflammatory Myelopathies --- Inflammatory Myelopathy --- Myelitides --- Myelitides, Subacute Necrotizing --- Myelitis, Infectious --- Myelitis, Subacute Necrotizing --- Myelopathies, Inflammatory --- Necrotizing Myelitides, Subacute --- Necrotizing Myelitis, Subacute --- Spinal Cord Inflammations --- Subacute Necrotizing Myelitides --- Nervous System Disorders --- Neurological Disorders --- Neurologic Disorders --- Disease, Nervous System --- Diseases, Nervous System --- Disorder, Nervous System --- Disorder, Neurologic --- Disorder, Neurological --- Disorders, Nervous System --- Disorders, Neurologic --- Disorders, Neurological --- Nervous System Disease --- Nervous System Disorder --- Neurologic Disorder --- Neurological Disorder --- Neurology --- Degenerative Diseases, Central Nervous System --- Degenerative Diseases, Neurologic --- Degenerative Diseases, Spinal Cord --- Degenerative Neurologic Diseases --- Degenerative Neurologic Disorders --- Nervous System Degenerative Diseases --- Neurodegenerative Disorders --- Neurologic Degenerative Conditions --- Neurologic Degenerative Diseases --- Neurologic Diseases, Degenerative --- Degenerative Diseases, Nervous System --- Degenerative Condition, Neurologic --- Degenerative Conditions, Neurologic --- Degenerative Neurologic Disease --- Degenerative Neurologic Disorder --- Neurodegenerative Disease --- Neurodegenerative Disorder --- Neurologic Degenerative Condition --- Neurologic Degenerative Disease --- Neurologic Disease, Degenerative --- Neurologic Disorder, Degenerative --- Neurologic Disorders, Degenerative --- Atrophic Muscular Disorders --- Spinopontine Atrophy --- Atrophy, Disuse --- Atrophy, Spinopontine --- Atrophic Muscular Disorder --- Atrophies, Disuse --- Atrophies, Spinopontine --- Disorder, Atrophic Muscular --- Disorders, Atrophic Muscular --- Disuse Atrophies --- Disuse Atrophy --- Muscular Disorder, Atrophic --- Spinopontine Atrophies --- Muscular Atrophy --- Encephalitis, Polio --- Epidemic Acute Poliomyelitis --- Polio Encephalitis --- Poliomyelitis Infection --- Poliomyelitis, Acute --- Infantile Paralysis --- Polio --- Poliomyelitis, Nonpoliovirus --- Poliomyelitis, Preparalytic --- Acute Poliomyelitis --- Acute Poliomyelitis, Epidemic --- Infection, Poliomyelitis --- Infections, Poliomyelitis --- Nonpoliovirus Poliomyelitis --- Paralysis, Infantile --- Poliomyelitides, Preparalytic --- Poliomyelitis Infections --- Poliomyelitis, Epidemic Acute --- Polios --- Preparalytic Poliomyelitis --- Post-polio syndrome --- Postpolio syndrome --- Postpoliomyelitis muscular atrophy --- Muscular atrophy --- Syndromes --- Post-Poliomyelitis Muscular Atrophy --- Muscular Atrophy, Postpoliomyelitis --- Post-Polio Syndrome --- Post-Poliomyelitis Syndrome --- Postpoliomyelitis Muscular Atrophy --- Muscular Atrophies, Post-Poliomyelitis --- Muscular Atrophies, Postpoliomyelitis --- Muscular Atrophy, Post-Poliomyelitis --- Post Poliomyelitis Muscular Atrophy --- Post Poliomyelitis Syndrome --- Post-Polio Syndromes --- Post-Poliomyelitis Muscular Atrophies --- Postpoliomyelitis Muscular Atrophies --- Infections, RNA Virus --- Infection, RNA Virus --- RNA Virus Infection --- Virus Infection, RNA --- Virus Infections, RNA --- Viral Diseases --- Viral Infections --- Virus Infections --- Disease, Viral --- Disease, Virus --- Diseases, Viral --- Diseases, Virus --- Infection, Viral --- Infection, Virus --- Infections, Viral --- Infections, Virus --- Viral Disease --- Viral Infection --- Virus Disease --- Virus Infection --- Infections, Picornaviridae --- Infections, Picornavirus --- Picornavirus Infections --- Infection, Picornaviridae --- Infection, Picornavirus --- Picornaviridae Infection --- Picornavirus Infection --- Orthopedic Disorders --- Musculoskeletal Disease --- Orthopedic Disorder --- CNS Diseases --- Central Nervous System Disorders --- CNS Disease --- Central Nervous System Disease --- Central Nervous System Disorder --- Central Nervous System Infection --- Infections, Central Nervous System --- CNS Infections --- CNS Infection --- Infection, CNS --- Infections, CNS --- Infections, Enterovirus --- Enterovirus Infection --- Infection, Enterovirus --- Cramp-Fasciculation Syndrome --- Fasciculation-Cramp Syndrome, Benign --- Foley-Denny-Brown Syndrome --- Oppenheim's Disease --- Amyotonia Congenita --- Oppenheim Disease --- Benign Fasciculation-Cramp Syndrome --- Benign Fasciculation-Cramp Syndromes --- Cramp Fasciculation Syndrome --- Cramp-Fasciculation Syndromes --- Fasciculation Cramp Syndrome, Benign --- Fasciculation-Cramp Syndromes, Benign --- Foley Denny Brown Syndrome --- Neuromuscular Disease --- Oppenheims Disease --- Syndrome, Cramp-Fasciculation --- Syndrome, Foley-Denny-Brown --- Syndromes, Cramp-Fasciculation --- Myopathic Conditions --- Muscle Disorders --- Myopathies --- Muscle Disorder --- Muscular Disease --- Myopathic Condition --- Myopathy --- Complications

Listing 1 - 10 of 23 << page
of 3
>>
Sort by